Evidence map›Paper›PMID 40342575›Full record

ArticleTherapeutic advances in ophthalmology

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment.

Andreas Stahl, Hidehiko Nakanishi, Domenico Lepore, Wei-Chi Wu, Noriyuki Azuma, Carlos Jacas, Aditya Athanikar, Robert Vitti, Karen Chu, Pablo Iveli and 8 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Andreas StahlDepartment of Ophthalmology, University Medicine Greifswald, Ferdinand Sauerbruch Straße, Greifswald 17475, Germany.ORCID https://orcid.org/0000-0002-8013-7597
Hidehiko NakanishiDivision of Neonatal Intensive Care Medicine, Department of Advanced Medicine, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
Domenico LeporeDepartment of Geriatrics and Neuroscience, Catholic University of the Sacred Heart, A. Gemelli Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
Wei-Chi WuDepartment of Ophthalmology, Linkou Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Noriyuki AzumaDepartment of Developmental and Regenerative Biology, Medical Research Institute, Institute of Science Tokyo, Tokyo, Japan.
Carlos JacasDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Aditya AthanikarRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Robert VittiRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Karen ChuRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Pablo IveliBayer AG, Wuppertal, Germany.
Fei ZhaoBayer, Inc., Mississauga, ON, Canada.
Sarah SchliefBayer AG, Berlin, Germany.
Sergio LealBayer Consumer Care AG, Basel, Switzerland.
Thomas SchmelterBayer AG, Berlin, Germany.
Thomas MillerBayer Healthcare LLC, Whippany, NJ, USA.
Evra KöfüncüBayer AG, Berlin, Germany.
Alistair FielderDepartment of Optometry and Visual Science, City St George's, University of London, London, UK.
FIREFLEYE Next Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

infantsintravitreal afliberceptretinopathy of prematurity

Identifiers

PMID40342575
PMCPMC12059413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.